CVS Health posts Q3 profit and lifts full‑year 2026 EPS and cash‑flow guidance
CVS Health reported third‑quarter 2026 revenue of $108.4 billion, up 5.4% year‑over‑year, and GAAP EPS of $1.68, reversing a loss from the prior year. Adjusted EPS rose to $2.09. The company raised its full‑year 2026 GAAP EPS guidance to at least $6.98 and adjusted EPS guidance to at least $8.20, and lifted cash‑flow‑from‑operations guidance to at least $15.5 billion. CEO David Joyner highlighted the strong results and the ongoing strategy to split the business by 2028.
Why it matters
The raised EPS and cash‑flow guidance signal stronger profitability and cash generation, which will likely improve financial models and valuation for investors. The guidance increase also reflects the impact of recent acquisitions and segment growth.
Key facts
- 1Third‑quarter total revenues increased to $108.4 billion, up 5.4% year‑over‑year. prnewswire.com
- 2GAAP diluted EPS for the quarter was $1.68. prnewswire.com
- 3Adjusted EPS for the quarter was $2.09. prnewswire.com
- 4Full‑year 2026 GAAP diluted EPS guidance was raised to at least $6.98, from a prior range of $6.84‑$7.04. prnewswire.com
- 5Full‑year 2026 adjusted EPS guidance was raised to at least $8.20, from a prior range of $7.90‑$8.10. prnewswire.com
- 6Full‑year 2026 cash‑flow‑from‑operations guidance was raised to at least $15.5 billion, from at least $11.5 billion. prnewswire.com
Summary written by AlphAI AI Desk from 11 of 11 sources. Not investment advice. Figures are as stated by the linked sources.